News

Ga-68 FAPI PET Improves Detection and Staging of Pancreatic Cancer

View more

Jan 05, 2024

PSMA-PET shows promise in patients with IBD

View more

Jan 05, 2024

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

View more

Jan 05, 2024

MRI comparable to Ga-68 PSMA PET/CT for prostate cancer diagnosis

View more

Jan 05, 2024

New PET Tracer Noninvasively Identifies Cancer Gene Mutation, Allows for More Precise Diagnosis and Therapy

View more

Jan 05, 2024

Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation

View more

Jan 05, 2024